Vermilion Energy Inc. (VET, VET.TO) has significantly reduced its investment in Coelacanth Energy Inc. through a substantial share disposal. The Canadian energy company offloaded 30 million common shares of Coelacanth at $0.76 per share, generating proceeds of $22.80 million in the transaction.
Stake Reduction Details
Prior to this divestment, Vermilion maintained a significant position in Coelacanth, controlling approximately 110.18 million common shares representing roughly 20.7% ownership of the outstanding shares. Following the share sale, the company’s stake in Coelacanth has been trimmed to 80.18 million common shares, now accounting for approximately 15.0% of the issued and outstanding common shares.
The transaction represents the disposal of more than 2% of Coelacanth’s total outstanding shares, marking a material reduction in Vermilion’s strategic position within the company. This move signals a potential shift in Vermilion’s investment strategy regarding its Coelacanth holding.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vermilion Energy Divests Coelacanth Holding, Reduces Stake From Over 20% To 15%
Vermilion Energy Inc. (VET, VET.TO) has significantly reduced its investment in Coelacanth Energy Inc. through a substantial share disposal. The Canadian energy company offloaded 30 million common shares of Coelacanth at $0.76 per share, generating proceeds of $22.80 million in the transaction.
Stake Reduction Details
Prior to this divestment, Vermilion maintained a significant position in Coelacanth, controlling approximately 110.18 million common shares representing roughly 20.7% ownership of the outstanding shares. Following the share sale, the company’s stake in Coelacanth has been trimmed to 80.18 million common shares, now accounting for approximately 15.0% of the issued and outstanding common shares.
The transaction represents the disposal of more than 2% of Coelacanth’s total outstanding shares, marking a material reduction in Vermilion’s strategic position within the company. This move signals a potential shift in Vermilion’s investment strategy regarding its Coelacanth holding.
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.